These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1676233)

  • 1. Antagonism of vecuronium paralysis: comparison between edrophonium and neostigmine.
    Dernovoi BS
    Acta Anaesthesiol Belg; 1991; 42(1):65-71. PubMed ID: 1676233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
    Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
    Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low and high frequency stimulation tests to characterize the effects of edrophonium on vecuronium-induced neuromuscular block.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Hennart DA; Cantraine FR
    Br J Anaesth; 1995 Jan; 74(1):12-5. PubMed ID: 7880697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study.
    Mirakhur RK
    Eur J Anaesthesiol; 1987 Nov; 4(6):411-9. PubMed ID: 3446491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade.
    Baurain MJ; d'Hollander AA; Melot C; Dernovoi BS; Barvais L
    Anesthesiology; 1991 Mar; 74(3):474-8. PubMed ID: 1672059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence and relative sensitivities of 50-Hz and 100-Hz tetanic stimuli on subsequent tetanic fade ratios in patients receiving vecuronium.
    Baurain MJ; Hoton F; Dernovoi BS; d'Hollander AA
    Anesth Analg; 1996 Jan; 82(1):139-42. PubMed ID: 8712390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edrophonium is better than neostigmine to antagonize residual vecuronium induced neuromuscular block.
    Puura AI; Baer GA; Rorarius MG
    Acta Anaesthesiol Belg; 1994; 45(4):161-6. PubMed ID: 7887118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block.
    Naguib M; Abdulatif M
    Anesth Analg; 1994 Feb; 78(2):306-11. PubMed ID: 8311284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Barvais L
    Anesthesiology; 1992 Jul; 77(1):17-20. PubMed ID: 1351705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.